Poultry Genetic Engineering Vaccine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510242509

Publication Date:

October 9, 2024

Pages:

158

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Poultry Genetic Engineering Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Poultry Genetic Engineering Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Poultry Genetic Engineering Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Poultry Genetic Engineering Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Poultry Genetic Engineering Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Poultry Genetic Engineering Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Poultry Genetic Engineering Vaccine by region & country, by Type, and by Application.
The Poultry Genetic Engineering Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry Genetic Engineering Vaccine.
麻豆原创 Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Beijing Ceva Huadu Biological Co., Ltd.
Harbin Weike BIOTECHNOLOGY Co., Ltd.
Segment by Type:
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Segment by Application
Chickens
Duck
Goose
Pigeon
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Poultry Genetic Engineering Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Poultry Genetic Engineering Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Poultry Genetic Engineering Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Poultry Genetic Engineering Vaccine Product Introduction
1.2 Global Poultry Genetic Engineering Vaccine 麻豆原创 Size Forecast
1.2.1 Global Poultry Genetic Engineering Vaccine Sales Value (2019-2030)
1.2.2 Global Poultry Genetic Engineering Vaccine Sales Volume (2019-2030)
1.2.3 Global Poultry Genetic Engineering Vaccine Sales Price (2019-2030)
1.3 Poultry Genetic Engineering Vaccine 麻豆原创 Trends & Drivers
1.3.1 Poultry Genetic Engineering Vaccine Industry Trends
1.3.2 Poultry Genetic Engineering Vaccine 麻豆原创 Drivers & Opportunity
1.3.3 Poultry Genetic Engineering Vaccine 麻豆原创 Challenges
1.3.4 Poultry Genetic Engineering Vaccine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Poultry Genetic Engineering Vaccine Players Revenue Ranking (2023)
2.2 Global Poultry Genetic Engineering Vaccine Revenue by Company (2019-2024)
2.3 Global Poultry Genetic Engineering Vaccine Players Sales Volume Ranking (2023)
2.4 Global Poultry Genetic Engineering Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Poultry Genetic Engineering Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Poultry Genetic Engineering Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Poultry Genetic Engineering Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Poultry Genetic Engineering Vaccine
2.9 Poultry Genetic Engineering Vaccine 麻豆原创 Competitive Analysis
2.9.1 Poultry Genetic Engineering Vaccine 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Poultry Genetic Engineering Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poultry Genetic Engineering Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Recombinant Vaccine
3.1.2 Recombinant Subunit Vaccines
3.1.3 Genetic Vaccine
3.2 Global Poultry Genetic Engineering Vaccine Sales Value by Type
3.2.1 Global Poultry Genetic Engineering Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Poultry Genetic Engineering Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Poultry Genetic Engineering Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Poultry Genetic Engineering Vaccine Sales Volume by Type
3.3.1 Global Poultry Genetic Engineering Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Poultry Genetic Engineering Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Poultry Genetic Engineering Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Poultry Genetic Engineering Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chickens
4.1.2 Duck
4.1.3 Goose
4.1.4 Pigeon
4.1.5 Other
4.2 Global Poultry Genetic Engineering Vaccine Sales Value by Application
4.2.1 Global Poultry Genetic Engineering Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Poultry Genetic Engineering Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Poultry Genetic Engineering Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Poultry Genetic Engineering Vaccine Sales Volume by Application
4.3.1 Global Poultry Genetic Engineering Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Poultry Genetic Engineering Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Poultry Genetic Engineering Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Poultry Genetic Engineering Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Poultry Genetic Engineering Vaccine Sales Value by Region
5.1.1 Global Poultry Genetic Engineering Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Poultry Genetic Engineering Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Poultry Genetic Engineering Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Poultry Genetic Engineering Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Poultry Genetic Engineering Vaccine Sales Volume by Region
5.2.1 Global Poultry Genetic Engineering Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Poultry Genetic Engineering Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Poultry Genetic Engineering Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Poultry Genetic Engineering Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Poultry Genetic Engineering Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
5.4.2 North America Poultry Genetic Engineering Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
5.5.2 Europe Poultry Genetic Engineering Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Poultry Genetic Engineering Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
5.7.2 South America Poultry Genetic Engineering Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Poultry Genetic Engineering Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Poultry Genetic Engineering Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Poultry Genetic Engineering Vaccine Sales Value
6.2.1 Key Countries/Regions Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Poultry Genetic Engineering Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.3.2 United States Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.4.2 Europe Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.5.2 China Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.6.2 Japan Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.7.2 South Korea Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Poultry Genetic Engineering Vaccine Sales Value, 2019-2030
6.9.2 India Poultry Genetic Engineering Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Poultry Genetic Engineering Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Poultry Genetic Engineering Vaccine Product Offerings
7.1.5 Merck Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Introduction and Business Overview
7.2.3 GSK Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GSK Poultry Genetic Engineering Vaccine Product Offerings
7.2.5 GSK Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Introduction and Business Overview
7.3.3 Sanofi Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi Poultry Genetic Engineering Vaccine Product Offerings
7.3.5 Sanofi Recent Development
7.4 Zoties
7.4.1 Zoties Company Information
7.4.2 Zoties Introduction and Business Overview
7.4.3 Zoties Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zoties Poultry Genetic Engineering Vaccine Product Offerings
7.4.5 Zoties Recent Development
7.5 Elanco
7.5.1 Elanco Company Information
7.5.2 Elanco Introduction and Business Overview
7.5.3 Elanco Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco Poultry Genetic Engineering Vaccine Product Offerings
7.5.5 Elanco Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Information
7.6.2 Boehringer Ingelheim Introduction and Business Overview
7.6.3 Boehringer Ingelheim Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Boehringer Ingelheim Poultry Genetic Engineering Vaccine Product Offerings
7.6.5 Boehringer Ingelheim Recent Development
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Company Information
7.7.2 Indian Immunologicals Introduction and Business Overview
7.7.3 Indian Immunologicals Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Indian Immunologicals Poultry Genetic Engineering Vaccine Product Offerings
7.7.5 Indian Immunologicals Recent Development
7.8 China Animal Husbandry Industry Co.,Ltd.
7.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
7.8.2 China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
7.8.3 China Animal Husbandry Industry Co.,Ltd. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 China Animal Husbandry Industry Co.,Ltd. Poultry Genetic Engineering Vaccine Product Offerings
7.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Development
7.9 Yebio Bioengineering Co., Ltd Of Qingdao
7.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
7.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
7.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Poultry Genetic Engineering Vaccine Product Offerings
7.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
7.10 Jinyu Bio-technology Co.,ltd.
7.10.1 Jinyu Bio-technology Co.,ltd. Company Information
7.10.2 Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
7.10.3 Jinyu Bio-technology Co.,ltd. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Jinyu Bio-technology Co.,ltd. Poultry Genetic Engineering Vaccine Product Offerings
7.10.5 Jinyu Bio-technology Co.,ltd. Recent Development
7.11 HVRI
7.11.1 HVRI Company Information
7.11.2 HVRI Introduction and Business Overview
7.11.3 HVRI Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 HVRI Poultry Genetic Engineering Vaccine Product Offerings
7.11.5 HVRI Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Introduction and Business Overview
7.12.3 Ringpu Biology Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Poultry Genetic Engineering Vaccine Product Offerings
7.12.5 Ringpu Biology Recent Development
7.13 Kyoto Biken Laboratories
7.13.1 Kyoto Biken Laboratories Company Information
7.13.2 Kyoto Biken Laboratories Introduction and Business Overview
7.13.3 Kyoto Biken Laboratories Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Kyoto Biken Laboratories Poultry Genetic Engineering Vaccine Product Offerings
7.13.5 Kyoto Biken Laboratories Recent Development
7.14 FATRO
7.14.1 FATRO Company Information
7.14.2 FATRO Introduction and Business Overview
7.14.3 FATRO Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 FATRO Poultry Genetic Engineering Vaccine Product Offerings
7.14.5 FATRO Recent Development
7.15 Ceva Sant茅 Animale
7.15.1 Ceva Sant茅 Animale Company Information
7.15.2 Ceva Sant茅 Animale Introduction and Business Overview
7.15.3 Ceva Sant茅 Animale Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Ceva Sant茅 Animale Poultry Genetic Engineering Vaccine Product Offerings
7.15.5 Ceva Sant茅 Animale Recent Development
7.16 Pulike Biological Engineering,Inc.
7.16.1 Pulike Biological Engineering,Inc. Company Information
7.16.2 Pulike Biological Engineering,Inc. Introduction and Business Overview
7.16.3 Pulike Biological Engineering,Inc. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Pulike Biological Engineering,Inc. Poultry Genetic Engineering Vaccine Product Offerings
7.16.5 Pulike Biological Engineering,Inc. Recent Development
7.17 Wuhan Hvsen Biotechnology CO.,LTD
7.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
7.17.2 Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
7.17.3 Wuhan Hvsen Biotechnology CO.,LTD Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Wuhan Hvsen Biotechnology CO.,LTD Poultry Genetic Engineering Vaccine Product Offerings
7.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Development
7.18 Jinhe Biotechnology Co., Ltd.
7.18.1 Jinhe Biotechnology Co., Ltd. Company Information
7.18.2 Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
7.18.3 Jinhe Biotechnology Co., Ltd. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Jinhe Biotechnology Co., Ltd. Poultry Genetic Engineering Vaccine Product Offerings
7.18.5 Jinhe Biotechnology Co., Ltd. Recent Development
7.19 Beijing Ceva Huadu Biological Co., Ltd.
7.19.1 Beijing Ceva Huadu Biological Co., Ltd. Company Information
7.19.2 Beijing Ceva Huadu Biological Co., Ltd. Introduction and Business Overview
7.19.3 Beijing Ceva Huadu Biological Co., Ltd. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Beijing Ceva Huadu Biological Co., Ltd. Poultry Genetic Engineering Vaccine Product Offerings
7.19.5 Beijing Ceva Huadu Biological Co., Ltd. Recent Development
7.20 Harbin Weike BIOTECHNOLOGY Co., Ltd.
7.20.1 Harbin Weike BIOTECHNOLOGY Co., Ltd. Company Information
7.20.2 Harbin Weike BIOTECHNOLOGY Co., Ltd. Introduction and Business Overview
7.20.3 Harbin Weike BIOTECHNOLOGY Co., Ltd. Poultry Genetic Engineering Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Harbin Weike BIOTECHNOLOGY Co., Ltd. Poultry Genetic Engineering Vaccine Product Offerings
7.20.5 Harbin Weike BIOTECHNOLOGY Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Poultry Genetic Engineering Vaccine Industrial Chain
8.2 Poultry Genetic Engineering Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Poultry Genetic Engineering Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Poultry Genetic Engineering Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Beijing Ceva Huadu Biological Co., Ltd.
Harbin Weike BIOTECHNOLOGY Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.